|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Diabetes Mellitus | |||||
| Insulin Resistance | |||||
| 2 | More general conditions related to this trial | ||||
| Endocrine System Diseases | |||||
| Glucose Metabolism Disorders | |||||
| Hyperinsulinism | |||||
| Metabolic Diseases | |||||
| 3 | Additional drug interventions recognized in this trial | ||||
| Insulin | |||||
| 4 | More general drug interventions related to this trial | ||||
| Hypoglycemic Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| 5 | Sponsors listed in this trial | ||||
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |||||